Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Diabetes Research|March 31, 2015
Pituitary adenylate cyclase-activating polypeptide protects glomerular podocytes from inflammatory injuriesKenichi Sakamoto, Kyoko Kuno, Minoru Takemoto, et al.
Aging Cell|June 3, 2025
Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled TrialMayumi Shoji, Hisaya Kato, Masaya Koshizaka, et al.
BMJ Open|May 4, 2026
Evaluation of the efficacy of empagliflozin in patients with preserved left ventricular ejection fraction undergoing transcatheter aortic valve implantation for aortic stenosis: protocol for a randomised, open-label, controlled studyShogo Okita, Hideki Kitahara, Mayumi Shoji, et al.
Asia Pacific Journal of Clinical Nutrition|September 29, 2021
Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trialTakuya Minamizuka, Masaya Koshizaka, Mayumi Shoji, et al.
Geriatrics & Gerontology International|December 8, 2023
Sex differences in symptom presentation and their impact on diagnostic accuracy in Werner syndromeHiyori Kaneko, Yoshiro Maezawa, Ayano Tsukagoshi-Yamaguchi, et al.
Aging|December 29, 2020
Time gap between the onset and diagnosis in Werner syndrome: a nationwide survey and the 2020 registry in JapanMasaya Koshizaka, Yoshiro Maezawa, Yukari Maeda, et al.
Scientific Reports|August 2, 2025
Tcf21 modulates fibroblast activation and promotes cardiac fibrosis after injury via Pdgfrb signalingYusuke Baba, Yoshiro Maezawa, Naomichi Kondo, et al.
Aging|May 2, 2023
Renal dysfunction, malignant neoplasms, atherosclerotic cardiovascular diseases, and sarcopenia as key outcomes observed in a three-year follow-up study using the Werner Syndrome RegistryYukari Maeda, Masaya Koshizaka, Mayumi Shoji, et al.
Aging|December 3, 2024
Less frequent skin ulcers among patients with Werner syndrome treated with pioglitazone: findings from the Japanese Werner Syndrome RegistryKazuto Aono, Masaya Koshizaka, Mayumi Shoji, et al.
Diabetes, Obesity & Metabolism|April 18, 2019
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study)Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, et al.
Pageof 3